BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2436982)

  • 1. Cervical adenocarcinoma arising in florid mesonephric hyperplasia: report of a case with immunocytochemical studies.
    Valente PT; Susin M
    Gynecol Oncol; 1987 May; 27(1):58-68. PubMed ID: 2436982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histogenetic origin of cervical mesonephric hyperplasia and mesonephric adenocarcinoma of the uterine cervix studied with immunohistochemical methods.
    Lang G; Dallenbach-Hellweg G
    Int J Gynecol Pathol; 1990; 9(2):145-57. PubMed ID: 1692008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesonephric adenocarcinoma (endometrioid type) of endocervix with diffuse mesonephric hyperplasia involving cervical wall and myometrium: an unusual case report.
    Menon S; Kathuria K; Deodhar K; Kerkar R
    Indian J Pathol Microbiol; 2013; 56(1):51-3. PubMed ID: 23924560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component.
    Clement PB; Young RH; Keh P; Ostör AG; Scully RE
    Am J Surg Pathol; 1995 Oct; 19(10):1158-71. PubMed ID: 7573674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesonephric Adenocarcinoma and Mesonephric-like Adenocarcinoma of the Urinary Tract.
    Xing D; Liang SX; Gao FF; Epstein JI
    Mod Pathol; 2023 Jan; 36(1):100031. PubMed ID: 36788068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Florid mesonephric hyperplasia of the cervix: a report of a case with review of the literature.
    Ayroud Y; Gelfand MM; Ferenczy A
    Int J Gynecol Pathol; 1985; 4(3):245-54. PubMed ID: 2414240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.
    Ferry JA; Scully RE
    Am J Surg Pathol; 1990 Dec; 14(12):1100-11. PubMed ID: 2252101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesonephric adenocarcinoma of the uterine cervix: A case report and review of the literature.
    Tekin L; Yazici A; Akbaba E; Akin MN
    J Pak Med Assoc; 2015 Sep; 65(9):1016-7. PubMed ID: 26338754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesonephric remnant hyperplasia of the cervix: a clinicopathologic analysis of 14 cases.
    Jones MA; Andrews J; Tarraza HM
    Gynecol Oncol; 1993 Apr; 49(1):41-7. PubMed ID: 8482559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesonephric adenocarcinoma of cervix: a case report.
    Gupta OP; Guirguis MN; Diejomaoh F
    Int J Gynaecol Obstet; 1988 Feb; 26(1):137-40. PubMed ID: 2892730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesonephric adenocarcinoma of the uterine cervix with focal endocrine cell differentiation.
    Stewart CJ; Taggart CR; Brett F; Mutch AF
    Int J Gynecol Pathol; 1993 Jul; 12(3):264-9. PubMed ID: 7688354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.
    Goyal A; Yang B
    Int J Gynecol Pathol; 2014 Nov; 33(6):613-9. PubMed ID: 25272301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesonephric adenocarcinoma of the cervix: a case report and review of the literature.
    Yap OW; Hendrickson MR; Teng NN; Kapp DS
    Gynecol Oncol; 2006 Dec; 103(3):1155-8. PubMed ID: 17023031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings.
    Silver SA; Devouassoux-Shisheboran M; Mezzetti TP; Tavassoli FA
    Am J Surg Pathol; 2001 Mar; 25(3):379-87. PubMed ID: 11224609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
    Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
    Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity For PAX2, PAX8, and GATA-3.
    Roma AA
    Int J Gynecol Pathol; 2014 Nov; 33(6):624-9. PubMed ID: 25272303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ; Richardson MS; Austin RM; Kurman RJ
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical Mesonephric Adenocarcinoma With Novel FGFR2 Mutation.
    Skala SL; Gregg PA; Orr JW; Udager AM; Brown NA; Cho KR
    Int J Gynecol Pathol; 2020 Sep; 39(5):452-455. PubMed ID: 31335448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor rupture as an initial manifestation of malignant mesonephric mixed tumor: a case report and review of the literature.
    Tseng CE; Chen CH; Chen SJ; Chi CL
    Int J Clin Exp Pathol; 2014; 7(3):1212-7. PubMed ID: 24696739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.